Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data?
TheFly reported on May 22 that FBLG released preclinical findings from its CYPS317 psoriasis program at the Society for Investigative Dermatology 2026 Annual Meeting.

